Showcasing Innovation at PHUSE US Connect 2023

PHUSE US Connect 2023 in Orlando delivered a week of incredible insight, conversation, and fun. As a people focused CRO, we showcased 3 presentations, 1 poster, took part in a panel on people leadership, and led a hands-on SCE workshop, which won Best in Stream in Emerging Trends & Technology.

View recordings of our work at PHUSE US below and get in touch to learn more about our innovative approach to biostatistics outsourcing.

Catch up on the presentations

A Journey Through Time and Resourcing – A Case Study for R Shell Scripts

Tom Ratford, Programmer 

Customizable Patient Profiles with R Shiny

Huw Wilson, Statistician 

Comparing Apples and Oranges: ISS Comparison

Elliot Pearn, Senior Programmer

From Graduate to Study Lead – What’s in my Toolkit?

Danielle John, Senior Programmer

Hot Topics At PHUSE US Connect 2023: Automation, R, And Open Source

As Premier Supporters of PHUSE, it was great to once again meet up with fellow industry leaders and innovators to share, learn and discuss where the bio-pharma space and world of biostatistics is heading. With so much buzz in the air and an eagerness to connect and share across the conference hall, we took the opportunity to showcase live demonstrations at our stand on the topic of R Programing, ISS/ISE, RWE, and Automation/SCE. Our workshops, posters and presentations expanded upon these topics and it evoked a sense of anticipation about how the industry is changing, especially in the field of Automation and SCE.

Matt Jones, our CEO, took part in a Leadership panel on the topic of Empathy and its relation to effective leadership – a core element of our ethos here at Veramed. Titled, Resilient and Empathic Leadership: Balancing Strategic Decisions and Growth with Empathy, the panel highlighted the importance of employee engagement and how best to tackle strategic changes inspire teams to reach their potential – acting as vital reminder for all 162 companies attending to never underestimate the power of their people.

Topics such as data standards, cloud computing, RWE and Data Management all came to the fore in what has become the new norm at such events such as PHUSE. Our very own Stuart Malcolm, Head of Automation, Standards and Efficiency at Veramed, gave us all a fantastic interactive workshop alongside our industry partners, Domino. Aptly titled, Next-generation Clinical Trials: Technology, People and Processes, the workshop closed out the event and took home the Best in Stream award in Emerging Trends and Technology – stay tuned for online recordings in the coming weeks.

Automation and SCE was on full display at PHUSE US Connect, and there’s an increasing number of vendors in the space that will add further efficiencies to the clinical trial journey, ensuring remedies get to patients even faster. Our Automation service line is a key part of this movement and our strategy going forward, and we’re excited to see how partnerships, such as our work with Domino, can make a difference for both big and small bio-pharma companies.

Learn more about our automation service line, headed by Stuart Malcolm here.

About Veramed

People. Data. Analysis. Decisions.

 

We bring people, innovation, and technology together to accelerate evidence generation and advance patient health. Discover what makes us different.

Download our brochure

We are a Certified B Corporation®

As a B Corp Certified ® business we meet the highest standards of social and environmental performance, transparency, and accountability. In making our business more accountable, we’re able to build trusting relationships with our clients and staff, exceed expectations and continuously improve on processes and innovation.

Download our 2022 Impact Report to learn more:

Click here

Scrip Awards

In 2022, we received the award for Best Contract Research Organization – Specialist Providers at the 18th Annual Scrip Awards, which honours the very best innovations and achievements in global biopharma.

300
Statisticians & Programmers
95%
Staff retention rate
110%
of carbon footprint offset
0
Critical FDA findings